Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Buy
478,276
+13,083
+3% +$57.7K ﹤0.01% 6500
2026
Q1
$1.68M Buy
465,193
+145,871
+46% +$505K ﹤0.01% 6577
2025
Q4
$1.09M Buy
319,322
+45,141
+16% +$219K ﹤0.01% 6987
2025
Q3
$1.86M Buy
274,181
+224,545
+452% +$1.85M ﹤0.01% 5946
2025
Q2
$676K Sell
49,636
-68,658
-58% -$648K ﹤0.01% 8459
2025
Q1
$644K Buy
118,294
+86,975
+278% +$493K ﹤0.01% 8347
2024
Q4
$155K Sell
31,319
-27,689
-47% -$145K ﹤0.01% 10989
2024
Q3
$309K Sell
59,008
-63,318
-52% -$365K ﹤0.01% 9533
2024
Q2
$839K Sell
122,326
-317,092
-72% -$2.9M ﹤0.01% 7001
2024
Q1
$4.52M Buy
439,418
+65,213
+17% +$482K ﹤0.01% 3787
2023
Q4
$3.1M Buy
374,205
+224,349
+150% +$1.61M ﹤0.01% 4511
2023
Q3
$937K Buy
149,856
+122,975
+457% +$533K ﹤0.01% 6762
2023
Q2
$117K Buy
+26,881
New +$59.7K ﹤0.01% 10820
2023
Q1
Sell
-53,961
Closed -$95.3K 13093
2022
Q4
$105K Buy
53,961
+32,326
+149% +$72.5K ﹤0.01% 10927
2022
Q3
$43K Buy
21,635
+7,470
+53% +$17.8K ﹤0.01% 12294
2022
Q2
$29K Sell
14,165
-78,365
-85% -$195K ﹤0.01% 12239
2022
Q1
$327K Sell
92,530
-59,363
-39% -$211K ﹤0.01% 10068
2021
Q4
$588K Sell
151,893
-75,421
-33% -$356K ﹤0.01% 8750
2021
Q3
$1.41M Buy
227,314
+146,118
+180% +$1.25M ﹤0.01% 6646
2021
Q2
$956K Sell
81,196
-231,729
-74% -$2.67M ﹤0.01% 7899
2021
Q1
$4.95M Buy
+312,925
New +$5.63M ﹤0.01% 3932

Other funds holding LFMD

Jeff Yass's LFMD Position: Q2 2026 in Review

Jeff Yass increased its LifeMD (LFMD) stake by 2.8% in Q2 2026, buying an estimated $57.7K and bringing the position to 478,276 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #6500.

Jeff Yass first reported a position in LFMD in Q1 2021 and has held it in 21 quarters since. The position peaked at $4.95M in Q1 2021. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Jeff Yass held 478,276 shares of LifeMD worth $1.98M as of Q2 2026.
  • Jeff Yass bought 13,083 LifeMD shares in Q2 2026, an estimated $57.7K.
  • LifeMD made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6500 holding.
  • Jeff Yass first reported a position in LifeMD in Q1 2021 and has held it in 21 quarters since.
  • Jeff Yass's LifeMD position peaked at $4.95M in Q1 2021.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.